文献速递系统性红斑狼疮

DNA甲基化定位揭示系统性红斑狼疮患者的基因调控效应

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.
PubMed 文献 · Ann Rheum Dis · 2018-02-01

研究对548例系统性红斑狼疮(SLE)患者和587例健康对照的外周血DNA进行Illumina HumanMethylation 450k BeadChip分析,并在7245个CpG位点识别并重复出SLE差异甲基化。I型干扰素调控基因甲基化降低最明显,466个差异甲基化CpG的顺式甲基化数量性状位点(cis-meQTL)富集SLE遗传关联,涉及7个SLE全基因组关联研究位点。

要点

  • SLE患者与健康对照间在7245个CpG位点存在差异甲基化,I型干扰素调控基因甲基化降低最明显。
  • 466个SLE差异甲基化CpG受cis-meQTL调控,其meQTL富集SLE遗传关联,含7个SLE GWAS位点。
  • 20个SLE差异甲基化CpG的甲基化变异与基因型相关,包括HLA-DQB2位点。

核心结论

  • 结果提示若干SLE遗传风险变异可能通过改变靶基因调控区的DNA甲基化水平影响表型。

研究设计与样本

  • 研究分析548例SLE患者和587例健康对照血液提取DNA的Illumina HumanMethylation 450k BeadChip(覆盖全基因组485 000个CpG位点)。
  • 利用同一批个体Illumina ImmunoChip上196 524个SNP的基因型数据进行cis-meQTL分析。

主要发现

  • 在SLE中识别并重复出7245个差异甲基化CpG位点。
  • 甲基化差异最大见于I型干扰素调控基因,SLE中呈甲基化降低。
  • 定位cis-meQTL并发现SLE中466个差异甲基化CpG的甲基化水平受遗传调控。
  • SLE差异甲基化CpG的meQTL富集SLE遗传关联,包括PTPRC(CD45)、MHC-class III、UHRF1BP1、IRF5、IRF7、IKZF3和UBE2L3七个SLE GWAS位点。
  • 观察到SLE中20个差异甲基化CpG的基因型与甲基化变异相关,包括HLA-DQB2位点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with heterogeneous presentation and complex aetiology where DNA methylation changes are emerging as a contributing factor. In order to discover novel epigenetic associations and investigate their relationship to genetic risk for SLE, we analysed DNA methylation profiles in a large collection of patients with SLE and healthy individuals. METHODS: DNA extracted from blood from 548 patients with SLE and 587 healthy controls were analysed on the Illumina HumanMethylation 450 k BeadChip, which targets 485 000 CpG sites across the genome. Single nucleotide polymorphism (SNP) genotype data for 196 524 SNPs on the Illumina ImmunoChip from the same individuals were utilised for methylation quantitative trait loci (cis-meQTLs) analyses. RESULTS: We identified and replicated differentially methylated CpGs (DMCs) in SLE at 7245 CpG sites in the genome. The largest methylation differences were observed at type I interferon-regulated genes which exhibited decreased methylation in SLE. We mapped cis-meQTLs and identified genetic regulation of methylation levels at 466 of the DMCs in SLE. The meQTLs for DMCs in SLE were enriched for genetic association to SLE, and included seven SLE genome-wide association study (GWAS) loci: PTPRC (CD45), MHC-class III, UHRF1BP1, IRF5, IRF7, IKZF3 and UBE2L3. In addition, we observed association between genotype and variance of methylation at 20 DMCs in SLE, including at the HLA-DQB2 locus. CONCLUSIONS: Our results suggest that several of the genetic risk variants for SLE may exert their influence on the phenotype through alteration of DNA methylation levels at regulatory regions of target genes.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, et al. DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018. PMID: 29437559. doi:10.1136/annrheumdis-2017-212379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。